Novel protein therapeutics for systolic heart failure: Chronic subcutaneous B-type natriuretic peptide

Journal of the American College of Cardiology

Volumn 60, Issue 22, 2012, Pages 2305-2312

  Chen, Horng H ^a   Glockner, James F ^a   Schirger, John A ^a   Cataliotti, Alessandro ^a   Redfield, Margaret M ^a   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; CYSTATIN C; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; DOPPLER ECHOCARDIOGRAPHY; DOPPLER MITRAL INFLOW VELOCITY TO MITRAL ANNULUS TISSUE DOPPLER VELOCITY RATIO; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EDEMA; FATIGUE; FEMALE; FLU LIKE SYNDROME; FLUSHING; FUNCTIONAL STATUS; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE MASS; HEART VOLUME; HUMAN; HYPERKALEMIA; HYPOTENSION; INJECTION SITE PRURITUS; LOOSE FECES; MALE; MINNESOTA LIVING WITH HEART FAILURE SCORE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SYSTOLIC HEART FAILURE; VISUAL DISORDER;

DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; NATRIURETIC PEPTIDE, BRAIN; PILOT PROJECTS; VENTRICULAR REMODELING;

EID: 84870239189     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.07.056     Document Type: Article

References (26)

1. S.A. Hunt, W.T. Abraham, M.H. Chin ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society J Am Coll Cardiol 46 2005 e1 e82
2. H.H. Chen, J.C. Burnett Jr Therapeutic potential for existing and novel forms of natriuretic peptides Heart Fail Clin 2 2006 365 373
3. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF) Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 2002 1531 1540
4. H.H. Chen Heart failure: a state of brain natriuretic peptide deficiency or resistance or both! J Am Coll Cardiol 49 2007 1089 1091
5. A.M. Hawkridge, D.M. Heublein, H.R. Bergen III, A. Cataliotti, J.C. Burnett Jr., D.C. Muddiman Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure Proc Natl Acad Sci U S A 102 2005 17442 17447
6. F. Liang, J. O'Rear, U. Schellenberger Evidence for functional heterogeneity of circulating B-type natriuretic peptide J Am Coll Cardiol 49 2007 1071 1078
7. H. Shimizu, K. Masuta, K. Aono Molecular forms of human brain natriuretic peptide in plasma Clin Chim Acta 316 2002 129 135
8. C.W. Yancy, M.T. Saltzberg, R.L. Berkowitz Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial) Am J Cardiol 94 2004 595 601
9. C.W. Yancy, H. Krum, B.M. Massie Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial Circ Heart Fail 1 2008 9 16
10. C.M. O'Connor, R.C. Starling, A.F. Hernandez Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
11. H.H. Chen, J.A. Grantham, J.A. Schirger, M. Jougasaki, M.M. Redfield, J.C. Burnett Jr Subcutaneous administration of brain natriuretic peptide in experimental heart failure J Am Coll Cardiol 36 2000 1706 1712
12. H.H. Chen, M.M. Redfield, L.J. Nordstrom, D.P. Horton, J.C. Burnett Jr Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure J Card Fail 10 2004 115 119
13. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr., D.W. Mahoney, K.R. Bailey, R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
14. H.H. Chen, F.L. Martin, R.J. Gibbons Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study Heart 95 2009 1315 1319
15. B.A. Groenning, J.C. Nilsson, L. Sondergaard, T. Fritz-Hansen, H.B. Larsson, P.R. Hildebrandt Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure J Am Coll Cardiol 36 2000 2072 2080
16. D.G. Kramer, T.A. Trikalinos, D.M. Kent, G.V. Antonopoulos, M.A. Konstam, and J.E. Udelson Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach J Am Coll Cardiol 56 2010 392 406
17. L.A. Brown, D.J. Nunez, M.R. Wilkins Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat J Clin Invest 92 1993 2702 2712
18. X. Lin, J. Hanze, F. Heese, R. Sodmann, R.E. Lang Gene expression of natriuretic peptide receptors in myocardial cells Circ Res 77 1995 750 758
19. M. Silberbach, C.T. Roberts Jr Natriuretic peptide signaling: molecular and cellular pathways to growth regulation Cell Signal 13 2001 221 231
20. J.B. Patel, M.L. Valencik, A.M. Pritchett, J.C. Burnett Jr., J.A. McDonald, M.M. Redfield Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload Am J Physiol Heart Circ Physiol 289 2005 H777 H784
21. T. Tsuruda, G. Boerrigter, B.K. Huntley Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases Circ Res 91 2002 1127 1134
22. A.M. Shah, H.A. Spurgeon, S.J. Sollott, A. Talo, E.G. Lakatta 8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes Circ Res 74 1994 970 978
23. J.G. Lainchbury, J.C. Burnett Jr., D. Meyer, M.M. Redfield Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs Am J Physiol Heart Circ Physiol 278 2000 H33 H40
24. P.B. Clarkson, N.M. Wheeldon, R.J. MacFadyen, S.D. Pringle, T.M. MacDonald Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure Circulation 93 1996 2037 2042
25. H.H. Chen, J.A. Schirger, A. Cataliotti, J.C. Burnett Jr Intact acute cardiorenal and humoral responsiveness following chronic subcutaneous administration of the cardiac peptide BNP in experimental heart failure Eur J Heart Fail 8 2006 681 686
26. F. Zannad, J.J. McMurray, H. Krum Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21